Connection

Bart Rijnders to Hepatitis C

Back to Details
This is a "connection" page, showing publications Bart Rijnders has written about Hepatitis C.
Bart Rijnders
Connection Strength
1.742
Hepatitis C
  1. Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterol Hepatol. 2019 04; 4(4):269-277.
    View in: PubMed
    Score: 0.333
  2. Case series on acute HCV in HIV-negative men in regular clinical practice: a call for action. Neth J Med. 2018 10; 76(8):374-378.
    View in: PubMed
    Score: 0.326
  3. Acute hepatitis C in HIV-negative men who have sex with men in the Netherlands and Belgium: a call for action. Sex Transm Infect. 2018 06; 94(4):297.
    View in: PubMed
    Score: 0.319
  4. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it? J Int AIDS Soc. 2018 04; 21 Suppl 2:e25062.
    View in: PubMed
    Score: 0.315
  5. HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study. J Int AIDS Soc. 2017 06 30; 20(1):21621.
    View in: PubMed
    Score: 0.299
  6. Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients. J Acquir Immune Defic Syndr. 2017 10 01; 76(2):193-199.
    View in: PubMed
    Score: 0.076
  7. Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients. J Gen Virol. 2017 Jun; 98(6):1294-1298.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.